ArticleFrontiers in medicine2026
Teprotumumab N01 for thyroid eye disease in China: clinical outcomes and quantitative MRI correlations.
Qiuyu Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it